Prolia 60mg Injection

Composition

Denosumab (60mg)

Therapeutic Use

Active Ingredient: Denosumab - A fully human monoclonal antibody that inhibits bone resorption by specifically targeting RANK Ligand., Administration: Subcutaneous injection once every 6 months. Easy twice-yearly dosing., Indication: Treatment of osteoporosis in postmenopausal women at high risk for fracture. Increases bone mineral density and reduces fracture risk., Mechanism: Binds to RANK Ligand, preventing it from activating osteoclasts which are responsible for breaking down bone tissue. Thus it reduces bone resorption and increases bone mass and strength., Dosage Strength: 60mg in a single-use prefilled syringe. Offers 6-month bone protection with one injection., Storage: Refrigerate at 2°C to 8°C in original carton. It should not be frozen or shaken. Stable for 24 hours at room temperature., Safety: Well tolerated with a favorable benefit-risk profile. Common side effects include back pain, pain in extremities, and musculoskeletal pain.